Pediatr. praxi. 2012;13(5):296-298

Current trends in haemophilia treatment for children

MUDr.Světlana Köhlerová
Oddělení dětské hematologie, Centrum pro trombózu a hemostázu, Hemofilické centrum
Dětská nemocnice &ndash, Fakultní nemocnice Brno

Even today the treatment of persons with haemophilia is still based on the substitution of missing clotting factor via intravenous injection.

Still more and more haemophiliacs (mainly children) are treated with recombinant clotting factor concentrates. The gold standard

for the treatment of severe haemophilia in children is the prophylactic factor administration, ideally in home settings, where the patient

or another family member, administers the medication himself.

Keywords: haemophilia, Factor VIII, Factor IX, prophylaxis

Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Köhlerová S. Current trends in haemophilia treatment for children. Pediatr. praxi. 2012;13(5):296-298.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Penka M, Tesařová E, a kol. Hematologie a transfuzní lékařství I., 2011: 244-245.
    2. Brackmann HH, Effenberger W, Hess L, et al. Immune tolerance induction: a role for recombinant activated factor VII (rFVIIa)? Eur J Haematols 1998; (Suppl.)63: 18-23.
    3. Giangrande PL. Adverse events in the prophylaxis of haemophilia. Haemophilia 2003; 9(Suppl. 1): 50-54. Go to original source... Go to PubMed...
    4. Gouw SC, Van den Berg HM, Le Celsie S, et al. Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia. A. J tromb Haemost. 2007; 5: 1383-1390. Go to original source... Go to PubMed...
    5. Kurnik K, Bidlingmaier C, Engl W, et al. New early prophylaxis regimen that avoids immunogical danger sinals can reduce FVIII inhibitor development. Haemophilia 2010; 16: 256-262. Go to original source... Go to PubMed...
    6. Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint dinase in boys with severe hemophilia. N Engl J Med, 2007; 357: 535-544. Go to original source... Go to PubMed...
    7. Gringeri A, Lundin B, Von Mackensen S, et al. A randomised clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Stud.) Journal of Thrombosis and Haemostasis 2011; 9: 700-710. Go to original source... Go to PubMed...
    8. Gouw SC, Van der Bom JG, Auerswald G, et al. Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study. Blood 2007; 109: 4693-4697. Go to original source... Go to PubMed...
    9. Blatný J, Blažek B. Rekombinantní faktory krevního srážení v léčbě hemofilie. Postgraduální medicína 2012; 14(2): 211-214.

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.